Reserved for future guideline expansion
D65
BookmarkDisseminated intravascular coagulation [defibrination syndrome]
Filed alongside this entry 43
under Purpura
- abdominal D69.0
- allergic D69.0
- anaphylactoid D69.0
- annularis telangiectodes L81.7
- arthritic D69.0
- autoerythrocyte sensitization D69.2
- autoimmune D69.0
- bacterial D69.0
- Bateman's (senile) D69.2
- capillary fragility (hereditary) (idiopathic) D69.8
- cryoglobulinemic D89.1
- Devil's pinches D69.2
- fulminans, fulminous D65
- gangrenous D65
- hemorrhagic, hemorrhagica D69.3
- Henoch (-Schönlein) (allergic) D69.0
- hypergammaglobulinemic (benign) (Waldenström) D89.0
- idiopathic (thrombocytopenic) D69.3
- immune thrombocytopenic D69.3
- infectious D69.0
- malignant D69.0
- neonatorum P54.5
- nervosa D69.0
- newborn P54.5
- nonthrombocytopenic D69.2
- nonthrombopenic D69.2
- peliosis rheumatica D69.0
- posttransfusion (post-transfusion) (from (fresh) whole blood or blood products) D69.51
- primary D69.49
- red cell membrane sensitivity D69.2
- rheumatica D69.0
- Schönlein (-Henoch) (allergic) D69.0
- scorbutic E54
- senile D69.2
- simplex D69.2
- symptomatica D69.0
- telangiectasia annularis L81.7
- thrombocytopenic D69.49
- thrombopenic D69.49
- thrombotic, thrombocytopenic M31.19
- toxic D69.0
- vascular D69.0
- visceral symptoms D69.0
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
Billable FY2027 2026-10-01 → 2027-09-30
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions14never code together
D65code
Excludes1
D50-D89chapter
Excludes2
- autoimmune disease (systemic) NOS (M35.9)M35.9
- certain conditions originating in the perinatal period (P00-P96)P00-P96
- complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
- endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
- human immunodeficiency virus [HIV] disease (B20)B20
- injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
- neoplasms (C00-D49)C00-D49
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes8
D65code
Inclusion terms
- Afibrinogenemia, acquired
- Consumption coagulopathy
- COVID-19 associated diffuse or disseminated intravascular coagulopathy
- Diffuse or disseminated intravascular coagulation [DIC]
- Fibrinolytic hemorrhage, acquired
- Fibrinolytic purpura
- Purpura fulminans
Code also
- , if applicable, associated condition
Official Guidelines1names this code
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
Index entries leading here14
- Absence (of) (organ or part) (complete or partial)
- Afibrinogenemia D68.8
- acquired D65
- Fibrinogenopenia D68.8
- acquired D65
- Hypofibrinogenemia D68.8
- acquired D65
- Deficiency, deficient
- Coagulation, intravascular (diffuse) (disseminated) — see also Defibrination syndrome
- COVID-19 associated D65
- Coagulopathy — see also Defect, coagulation
- Glomerulonephritis N05.9
- Defibrination (syndrome) D65
- Syndrome — see also Disease
- Disorder (of) — see also Disease
- Fibrinolysis (hemorrhagic) (acquired) D65
- Purpura D69.2
- Proteolysis, pathologic D65
Medications1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.